Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 1/2000

Sonderheft 1/2000

Second International Symposium on the Molecular Biology of Breast Cancer

Inhaltsverzeichnis ( 102 Artikel )

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Denaturing high-performance liquid chromatography (DHPLC) as a fast tool to screen a control population for the occurrence of unclassified variants (UV) in the BRCA1 gene

01.03.2000 | Meeting abstract | Sonderheft 1/2000

A novel BRCA2 gene mutation, 4081 insA, in a Finnish breast/ovarian cancer family associated with favourable clinical course

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2

01.03.2000 | Meeting abstract | Sonderheft 1/2000

BRCA1mutation analysis in breast and ovarian cancer families from Greece

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Germline TP53mutations in Finnish breast cancer patients

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Germline BRCA2 and somatic P53alterations in male breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families

01.03.2000 | Meeting abstract | Sonderheft 1/2000

kConFab: a unique Australasian research initiative for familial breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Relative expression of progesterone receptors A and B in premalignant and invasive breast lesions

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells

01.03.2000 | Meeting abstract | Sonderheft 1/2000

The expression of the EGFR family members in breast carcinomas

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Anti-HER2 mAb plus calicheamicin immunoconjugate linked on liposomal vinorelbine induces ADCC and apoptosis in HER2-positive high grade DCIS

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Herceptin™ (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

01.03.2000 | Meeting abstract | Sonderheft 1/2000

P53 mutations in breast and ovarian carcinomas from BRCA1 and 2 mutation carriers and noncarriers

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Constitutional alterations of the ATM gene in early-onset sporadic breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Modulation of ATM gene expression in a murine mammary epithelial cell line

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Loss of heterozygosity on chromosome arm 16q in breast cancer: clinical, molecular and statistical approaches

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Excluding TTC4 as a target for loss on chromosome 1p31 in human breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Low frequency of p16 INK4a promoter methylation in mammary carcinomas as revealed by positive display of methylated sites

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Estrogen-dependent c-jun upregulation may control cyclin D1 expression

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Development of a high throughput, molecular diagnostic assay for predicting telomerase activity in breast cancer cell lines and tissues

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Molecular analyses of human breast cancer metastasis: genetic markers of progression

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Genetic alterations in ductal carcinoma in situ and invasive carcinoma of the breast

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Identification of two novel breast cancer associated genes by the differential display method

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Expression profiling of BRCA1 associated breast tumors

01.03.2000 | Oral presentation | Sonderheft 1/2000

The importance of breast cancer research from a patient's view: the voices and visions of advocates

01.03.2000 | Oral presentation | Sonderheft 1/2000

Genetic testing for BRCA1 and BRCA2 mutations - ready for implementation?

01.03.2000 | Oral presentation | Sonderheft 1/2000

The pathology of inherited breast tumours

01.03.2000 | Oral presentation | Sonderheft 1/2000

Other cancers in BRCA1 and BRCA2 mutation carriers: implications for counselling and follow up

01.03.2000 | Oral presentation | Sonderheft 1/2000

The role of coactivators in oestrogen action

01.03.2000 | Oral presentation | Sonderheft 1/2000

Growth regulation and steroid hormone resistance in breast cancer

01.03.2000 | Oral presentation | Sonderheft 1/2000

Clinical translation of progress in molecular endocrinology

01.03.2000 | Oral presentation | Sonderheft 1/2000

Use of the anti HER-2/neu antibody Herceptin in the treatment of human breast cancer: biological rationale and clinical results

01.03.2000 | Oral presentation | Sonderheft 1/2000

Characterisation of micrometastatic tumor cells

01.03.2000 | Oral presentation | Sonderheft 1/2000

Animal models of human tumor suppressor genes

01.03.2000 | Oral presentation | Sonderheft 1/2000

Drug discovery in the p53 pathway

01.03.2000 | Oral presentation | Sonderheft 1/2000

Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium

01.03.2000 | Oral presentation | Sonderheft 1/2000

p53-mediated apoptosis and genomic instability syndromes

01.03.2000 | Oral presentation | Sonderheft 1/2000

Lessons from TP53mutations in breast cancers: from carcinogen fingerprints to clinical correlates

01.03.2000 | Oral presentation | Sonderheft 1/2000

p53 action in apoptosis and senescence

01.03.2000 | Oral presentation | Sonderheft 1/2000

Cancer susceptibility in ATM heterozygotes: do two distinct carrier populations exist?

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up

01.03.2000 | Meeting abstract | Sonderheft 1/2000

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

One test to identify 50% of all Norwegian BRCA1 mutations

01.03.2000 | Meeting abstract | Sonderheft 1/2000

X chromosome inactivation pattern in female patients with breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

HRAS1 minisatellite alleles and breast cancer in Spanish women under age forty years

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Hairy and enhancer of split homolog-1 (HES-1) mediates the proliferative effect of Beta-estradiol on breast cancer cell lines

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Genetic variants of CYP19 (aromatase) and breast cancer risk

01.03.2000 | Meeting abstract | Sonderheft 1/2000

The involvement of the MAPK signalling pathway in the adaptation of MCF-7 cells to long-term oestrogen deprivation

01.03.2000 | Meeting abstract | Sonderheft 1/2000

IGFBP-7 expression in human breast cancer and association with proliferation and cell cycle aberrations

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Factors modulating integrin Beta I expression on the breast cancer cell lines MCF-7 and MDA-MB-231

01.03.2000 | Meeting abstract | Sonderheft 1/2000

HER-2 activation and TP53 inactivation as predictors of survival in breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Role of the breast cancer susceptibility gene BRCA1 in radio-resistance

01.03.2000 | Meeting abstract | Sonderheft 1/2000

BRCA2 interacting proteins

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Embryonic lethality in the Brca1-1700T mouse model suggests inhibition of p53-dependent pathways

01.03.2000 | Meeting abstract | Sonderheft 1/2000

The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Screening breast cancer patients for Norwegian ATM mutations

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Analysis of Fhit expression in stages of breast cancer progression

01.03.2000 | Meeting abstract | Sonderheft 1/2000

A detailed physical map of a region within human chromosome 16q22.1

01.03.2000 | Meeting abstract | Sonderheft 1/2000

p16INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Negative regulation of p53 expression is an essential, rate-limiting function of Jun in the control of cell cycle progression

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Setting up an efficient and reliable screening method for novel c-Jun N-terminal kinase substrates

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Angiogenesis in breast cancer: establishing a link between angiogenesis and hormone regulation

01.03.2000 | Meeting abstract | Sonderheft 1/2000

AKT-1 and BCL-2 co-expression in breast cancer patients correlates with better survival

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Does a polymorphism in the CYP17 gene predict mammographic density?

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Promising method for DNA extraction from paraffin embedded archive material

01.03.2000 | Meeting abstract | Sonderheft 1/2000

REAL Real-Time!

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Exact quantification of gene amplification in archival tissue sections by laser-assisted microdissection and real-time PCR

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Hypervariable area in the 5' flanking region of GSTP1, previously reported as a minisatellite repeat

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Comparative genomic hybridisation analysis of myoepithelial carcinoma of the breast

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Transcript profiles and genotyping of cancer tissue

01.03.2000 | Meeting abstract | Sonderheft 1/2000

Relation of gene expression-based tumor subclasses to clinical phenotypes

01.03.2000 | Oral presentation | Sonderheft 1/2000

Molecular characteristics of inherited breast tumors

01.03.2000 | Oral presentation | Sonderheft 1/2000

Estrogen receptors α and β in the rodent mammary gland

01.03.2000 | Oral presentation | Sonderheft 1/2000

The EGF receptor family as targets for breast cancer therapy

01.03.2000 | Oral presentation | Sonderheft 1/2000

Herceptin in clinical use - early 2000

01.03.2000 | Oral presentation | Sonderheft 1/2000

Role of the ATM gene in radiation sensitivity, relevance to breast cancer treatment

01.03.2000 | Oral presentation | Sonderheft 1/2000

Tumour-selective transcriptional targeting for breast cancer gene therapy

01.03.2000 | Oral presentation | Sonderheft 1/2000

G1/S control and its deregulation in cancer

01.03.2000 | Oral presentation | Sonderheft 1/2000

Molecular control of apoptosis in the breast

01.03.2000 | Speaker presentations | Sonderheft 1/2000

Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy

01.03.2000 | Oral presentation | Sonderheft 1/2000

Telomerase: a breast cancer chemopreventive and therapeutic target

01.03.2000 | Oral presentation | Sonderheft 1/2000

Blood assays for earlier detection of cancers

01.03.2000 | Oral presentation | Sonderheft 1/2000

Predictive factors in breast cancer

01.03.2000 | Oral presentation | Sonderheft 1/2000

Clinical trials in breast cancer; do we have the right approaches?

01.03.2000 | Oral presentation | Sonderheft 1/2000

Tissue microarrays for high-throughput profiling in molecular oncology

01.03.2000 | Oral presentation | Sonderheft 1/2000

Two molecular cytogenetic views of breast cancer

01.03.2000 | Oral presentation | Sonderheft 1/2000

Studying breast cancer on a genomic scale using DNA microarrays

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise